10-KThe Record
Enliven Therapeutics, Inc. files 10-K
Filed Mar 15, 2022 · 4y ago · Accession 0001564590-22-010216
Plain English
Annual report — full-year financials, business overview, and risk factors.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 10-K
- Filing date
- Mar 15, 2022
- Report date
- Dec 31, 2021
- Document
- imra-10k_20211231.htm
- Size
- 11.2 MB